🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recent studies suggest that patients with metastatic melanoma whose gut mic...
Status
Completed
Location
Ambroise Paré
Start Date
2022-01-20
Trial ID
NCT04988841
Treatments Being Tested
The study aims to evaluate the 6 month-treatment tolerance defined as the i...
Status
Completed
Location
Gustave Roussy
Start Date
2016-12-05
Trial ID
NCT02857569
Treatments Being Tested
Phase I/II clinical trial on the per-operative intra-tumoral administration...
Status
Active Not Recruiting
Location
Universitair Ziekenhuis Brussel
Start Date
2016-11-17
Trial ID
NCT03233152
The main goal of this research study is to determine how nivolumab and nivo...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-09-02
Trial ID
NCT04401995
Treatments Being Tested
The purpose of this study is to assess objective response rate (partial and...
Status
Terminated
Location
Gustave Roussy
Start Date
2023-03-24
Trial ID
NCT05119010
The effect of nivolumab on symptomatic brain metastases is currently unknow...
Status
Terminated
Location
Dutch Cancer Institute/ A v. Leeuwenhoek Hospital
Start Date
2016-08
Trial ID
NCT02621515
Treatments Being Tested
The purpose of this study is to find out what effects (good and bad) immuno...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2018-03-15
Trial ID
NCT03406715
Treatments Being Tested
A randomized phase II clinical trial of SBRT and systemic pembrolizumab wit...
Status
Unknown
Location
Universitair Ziekenhuis Brussel
Start Date
2020-09-22
Trial ID
NCT04571632
Metastatic prostate cancer is an incurable disease that typically spreads b...
Status
Unknown
Location
Hospital Son Llatzer
Start Date
2019-02-11
Trial ID
NCT03879122
Treatments Being Tested
This trial is designed to investigate the safety, response rates and surviv...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2024-07-01
Trial ID
NCT06492408
Treatments Being Tested